Number of Shares
3,998.00
Current Holdings Value*
kr130,330.00
% of Portfolio
2.88%
Total Estimate Gain
kr1.04 Mil
% of Total Estimate Gain
75.86%

BMO Alternative Strategies Fund's Novo Nordisk AS Holding Summary

As of 2020-05-31, BMO FUNDS, INC. held 3,998.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr130,330.00. This investment constitutes 2.88% of their stock portfolio, and BMO FUNDS, INC. now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2019Q4. And since then BMO Alternative Strategies Fund has made 1 purchases of OCSE:NOVO B, at an average price of kr184.23, for a total of 7,430.00 shares. In addition, there have been 1 sales at an average price of kr207.59 for 3,432.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr423.90, BMO Alternative Strategies Fund's estimated gain on his OCSE:NOVO B holdings is kr1.04 Mil, reflecting a 75.86% gain to date.

BMO Alternative Strategies Fund OCSE:NOVO B (kr423.90) Holding Chart

BMO Alternative Strategies Fund OCSE:NOVO B (kr423.90) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1